Hemimandibular hyperplasia

Hemimandibular hyperplasia (HH) is a developmental, non-neoplastic growth abnormality characterized by progressive three-dimensional enlargement of one hemimandible, involving the condyle, condylar neck, ramus, and body, with the anomaly characteristically terminating at the midline symphysis.[1][2] The etiology remains uncertain; the prevailing hypothesis attributes the condition to persistent or accelerated activity of the condylar growth center beyond the normal period of skeletal maturation, possibly influenced by hormonal, traumatic, or genetic factors.[3] Pathogenesis centers on abnormally prolonged endochondral ossification at the condylar cartilage.[4][5] The signature radiographic pattern is unilateral enlargement of the condyle, increased ramus height, increased mandibular body height with inferior convexity of the lower border, and inferior displacement of the mandibular canal.[6] Management is surgical, combining condylectomy to arrest active growth with orthognathic surgery to correct the resulting dentofacial deformity.[7][8]

Current classification

The Obwegeser and Makek classification, introduced in 1986, remains the most widely referenced clinical framework. It divides unilateral condylar hyperplasia (UCH) into two principal entities based on the predominant growth vector:[3][4]

• Hemimandibular hyperplasia (HH): three-dimensional (vertical and transverse) enlargement of the hemimandible, producing a notable vertical discrepancy and occlusal cant.
• Hemimandibular elongation (HE): predominantly horizontal displacement of the mandible toward the unaffected side, with the condyle typically normal in size.
• Hybrid forms combining features of both are recognized.[3][9]

Wolford et al. proposed a more comprehensive system integrating clinical, imaging, and histological features into four types, with Type 2 (osteochondroma-driven vertical overgrowth) most closely overlapping the classic HH phenotype.[3][10] Gateno et al. have challenged the bimodal HH/HE distinction, demonstrating that growth vectors in UCH are unimodally distributed, with most cases growing diagonally rather than purely vertically or horizontally.[11]

Aliases and obsolete terms

The condition has been referred to as condylar hyperplasia, unilateral condylar hyperplasia, and mandibular condylar hyperplasia. The term "condylar hyperplasia" alone is imprecise and should not be used interchangeably with HH, as it encompasses entities with different morphologic features.[6]

• Age: Onset typically occurs during puberty, most commonly between ages 10 and 30, becoming clinically apparent when the affected condyle continues growing after contralateral cessation. Symptom recognition peaks at ages 13–15.[3][4][12]
• Sex: A female predominance has been reported in several series, though some authors attribute this to greater treatment-seeking behavior among women rather than a true biologic predilection.[3][12]
• Side: Neither side is consistently preferred.[3]
• Frequency: HH is uncommon. In a 10-year Polish cohort of 45 patients with condylar hyperplasia–associated asymmetry, HH accounted for the majority of cases. The condition is considerably rarer than developmental mandibular asymmetry from other causes.[12]

Presentation and symptoms

The chief complaint is progressive facial asymmetry, typically noticed during adolescence.[1][7] Cardinal clinical features include:

• Ipsilateral mandibular enlargement: fullness of the lower face on the affected side with increased vertical dimension of the ramus and body.[2][5]
• Chin deviation: the chin point deviates to the contralateral (unaffected) side.[1]
• Occlusal cant: the occlusal plane tilts downward on the affected side, producing an ipsilateral posterior open bite and compensatory supraeruption of maxillary teeth.[2][13]
• Inferior border prominence: a palpable convexity along the lower mandibular border on the affected side.[2][6]
• Malocclusion: crossbite on the contralateral side and Class III tendency on the affected side are common.[13][14]

Tempo and complications

Growth is slow and progressive; the condition is generally considered self-limiting, but the age at which growth ceases is unpredictable and may extend into the mid-20s.[3][10] Compensatory maxillary alveolar overgrowth follows the mandibular descent, worsening the occlusal cant over time.[2][5] Temporomandibular joint (TMJ) pain, crepitus, and limited opening may develop in advanced cases.[3] Soft-tissue asymmetry is secondary to the skeletal deformity and does not involve true soft-tissue hypertrophy, distinguishing HH from hemifacial hyperplasia.[15]

Location and distribution

HH is unilateral, involving the condyle, condylar neck, ramus, and body of the mandible on the affected side. The anomaly characteristically terminates abruptly at the mandibular symphysis, producing a visible "kink" at the midline.[1][2] Bilateral presentation is rare but has been described.[3]

Condylar morphology

The condyle is enlarged in all dimensions. The condylar head may be regularly enlarged (maintaining a smooth, rounded contour) or irregularly enlarged with a lobulated or asymmetric shape.[6] Anteroposterior condylar length and condylar volume are significantly increased compared with the contralateral side and normative values.[6] Unlike condylar osteochondroma, the enlarged condyle in HH typically maintains cortical continuity with the condylar neck without a discrete exophytic mass or pedunculated outgrowth.[6][10]

Ramus and mandibular body

• Ramus height is increased on the affected side, exceeding both the contralateral ramus and population norms.[6]
• Mandibular body height is increased in the premolar and molar regions, a feature that distinguishes HH from hemimandibular elongation, in which body height remains normal.[6]
• Inferior border convexity: the lower mandibular border on the affected side demonstrates a characteristic downward convexity (bowing), which is highly specific and sensitive for the diagnosis of HH.[6]

Effects on the mandibular canal and teeth

• Inferior displacement of the mandibular canal is a hallmark finding, with the canal displaced toward the inferior border on the affected side. This sign, combined with inferior border convexity, provides high diagnostic accuracy for HH.[6]
• Occlusal plane cant is visible on panoramic radiography as a downward tilt of the occlusal plane on the affected side.[1][13]
• Teeth on the affected side may show compensatory alveolar overgrowth; root resorption is not a typical feature.

Periphery and internal architecture

The cortex of the affected hemimandible is intact and of normal density; there is no periosteal reaction, cortical destruction, or pathologic fracture. The internal trabecular pattern is preserved, with normal-appearing cancellous bone throughout the enlarged ramus and body.[1][5] The absence of a discrete lesion, ground-glass opacity, or mixed radiolucent-radiopaque change within the bone distinguishes HH from fibrous dysplasia and neoplastic processes.

Growth pattern and extent

Three-dimensional imaging demonstrates that the enlargement is diffuse and proportional across the condyle, ramus, and body rather than focal.[6][16] Volumetric analysis confirms that the condyle is the most affected segment, but ramus and body volumes are also significantly increased compared with the contralateral side.[16] The maxilla on the affected side may show compensatory inferior displacement of the alveolar process and downward tilting of the palatal plane.[2][5]

Recognized variants

• Typical HH: full involvement of condyle, ramus, and body with prominent occlusal cant and inferior border convexity.[1]
• Atypical HH: milder forms with less pronounced body involvement or less occlusal cant; classified by Xu et al. to guide surgical planning.[1]
• Rare cases of non-condylar hemimandibular hyperplasia—enlargement of the ramus and body without condylar involvement—have been reported as isolated case reports and may represent a distinct entity.[17]

Nuclear medicine — bone scintigraphy

Technetium-99m methylene diphosphonate (Tc-99m MDP) bone scintigraphy, particularly SPECT or SPECT/CT, is the principal functional imaging modality for determining whether condylar growth is active. Increased radiotracer uptake in the affected condyle relative to the contralateral side indicates ongoing growth activity.[18][19][20]

• A relative uptake difference exceeding 8–10% between condyles is considered indicative of active condylar hyperplasia.[3][14][20]
• SPECT/CT offers improved sensitivity and reduced equivocal readings compared with planar scintigraphy.[18][20]
• Active scintigraphic uptake guides the decision to perform condylectomy to arrest growth, whereas inactive disease may be managed with orthognathic surgery alone.[14][21]

Scintigraphic activity does not correlate with the histological type or the thickness of individual cartilage layers.[19]

MRI

MRI may demonstrate the status of the TMJ disc and identify disc displacement, which is common on the contralateral side in advanced cases.[3] MRI is not required for diagnosis of HH but can be useful in preoperative planning when TMJ disc pathology is suspected.

The differential centers on entities that produce unilateral mandibular enlargement or condylar overgrowth. The combination of diffuse three-dimensional hemimandibular enlargement, inferior border convexity, inferior canal displacement, and absence of a discrete mass or altered internal architecture is characteristic of HH and helps distinguish it from focal neoplastic or dysplastic processes.

The highest-risk diagnostic pitfall is distinguishing HH from condylar osteochondroma, as both produce progressive unilateral vertical overgrowth and may coexist. Histopathologic examination of condylectomy specimens is essential when the condylar morphology is irregular or an exophytic component is suspected, as osteochondroma demonstrates a thicker cartilage cap, higher PCNA-positive cell counts, and EXT1 expression not seen in simple hyperplasia.[23]

Microscopic findings

The Slootweg and Müller classification describes a histological continuum of condylar hyperplasia:[3]

• Type I: thick, continuous proliferative layer merging into a hyaline cartilage zone, with cartilage rests within developing bone — indicative of active endochondral ossification.
• Type II: distinct fibrocartilaginous layer with hypertrophic chondrocyte columns; proliferative zones are discontinuous and patchy. Type II lesions are more frequently associated with TMJ symptoms.
• Type III: severely distorted architecture with broad hyaline cartilage patches intermingling with spongy bone of the condylar neck.
• Type IV: "burned-out" appearance with sparse chondrocytes and minimal proliferative layer, representing quiescent disease.

More advanced histological types correlate with more severe clinical deformity, but patient age does not predict the histological grade.[3]

Radiologic-pathologic correlation

Microcomputed tomography of condylectomy specimens reveals focal osteosclerotic areas corresponding to islands of calcified cartilage matrix with live chondrocytes persisting within the subchondral bone — a finding considered pathognomonic of UCH.[26] These foci of persistent endochondral ossification explain the progressive condylar enlargement seen on imaging.

Distinction from osteochondroma

Compared with condylar osteochondroma, HH specimens show a thinner cartilage cap, lower bone formation rate, fewer PCNA-positive proliferating cells, and lower EXT1 expression.[23] These differences support the concept that osteochondroma is a neoplastic process with higher proliferative activity, whereas HH represents a growth aberration.

Molecular findings

Somatic mosaicism for PIK3CA pathway mutations has been identified in condylar tissue from patients with UCH overlapping hemifacial hyperplasia, suggesting that at least some cases may share a molecular basis with other localized overgrowth disorders.[27] Elevated vascular endothelial growth factor (VEGF-A) expression has been reported in hyperplastic condylar cartilage, though its diagnostic or prognostic utility remains investigational.[3]

Assessment of growth activity

Determining whether condylar growth is active or quiescent is the critical first step, as it dictates surgical timing and approach. SPECT or SPECT/CT bone scintigraphy is the standard functional assessment; a relative condylar uptake difference exceeding 8–10% supports active disease.[3][20]